Neoplasm malignant and Duodenal perforation

Summary:

Duodenal perforation is reported only by a few people with Neoplasm malignant.

The study analyzes which people have Duodenal perforation with Neoplasm malignant. It is created by eHealthMe based on 5 people who have Duodenal perforation and Neoplasm malignant from the Food and Drug Administration (FDA), and is updated regularly.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Apr, 02, 2023

5 people who have Neoplasm Malignant and Duodenal Perforation are studied.

What is Neoplasm malignant?

Neoplasm malignant (cancer tumour) is found to be associated with 1,922 drugs and 1,231 conditions by eHealthMe.

What is Duodenal perforation?

Duodenal perforation (complication of duodenal ulcer) is found to be associated with 488 drugs and 258 conditions by eHealthMe.

Number of Duodenal perforation in Neoplasm malignant reports submitted per year:

Would you have Duodenal perforation when you have Neoplasm malignant?

Gender of people who have Neoplasm Malignant and experienced Duodenal Perforation *:

female: 75 %
male: 25 %

Age of people who have Neoplasm Malignant and experienced Duodenal Perforation *:

Common co-existing conditions for these people *:

Acute Febrile Neutrophilic Dermatosis (skin disease characterized by the sudden onset of fever, leukocytosis, and tender): 1 person, 20.00%

Common drugs taken by these people *:

Common symptoms for these people *:

Stress And Anxiety: 2 people, 40.00%
Stent Occlusion (blockage of stent): 2 people, 40.00%
Abdominal Pain: 2 people, 40.00%
Anaemia (lack of blood): 2 people, 40.00%
Appetite - Decreased (decreased appetite occurs when you have a reduced desire to eat): 2 people, 40.00%
Back Pain: 2 people, 40.00%
Bile Duct Obstruction (blockage in the tubes that carry bile from the liver to the gallbladder): 2 people, 40.00%
Bleeding Disorders: 2 people, 40.00%
Blood Alkaline Phosphatase Increased: 2 people, 40.00%
Cholangitis (infection of the bile duct): 2 people, 40.00%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Duodenal perforation?

Check whether Duodenal perforation is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related publications that referenced our studies

Kola E, Bakalli I, Celaj E, Lluka R, Heta S, Sallabanda S, "Stomach perforation from piroxicam poisoning", Paediatrics Today, 2012 Jun .

Related studies

Treatments, associated drugs and conditions:

Neoplasm malignant (88,986 reports)
Duodenal perforation (995 reports)

COVID vaccines that are related to Duodenal perforation:

All the drugs that are associated with Duodenal perforation:

Duodenal perforation (488 drugs)

All the conditions that are associated with Duodenal perforation:

Duodenal perforation (258 conditions)

How the study uses the data?

The study is based on Duodenal perforation and Neoplasm malignant, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.